Article
Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus.
Traffic (Copenhagen, Denmark) - 1 May 2015
Park Ji-Seon, Ji In Jung, An Hyun Joo, Kang Min-Ji, Kang Sang-Wook, Kim Dong-Hou, Yoon Seung-Yong
Abstract excerpt
The triggering receptor expressed on myeloid cells 2 (TREM2) is an immune-modulatory receptor involved in phagocytosis and inflammation. Mutations of Q33X, Y38C and T66M cause Nasu-Hakola disease (NHD) which is characterized by early onset of dementia and bone cysts. A recent, genome-wide association study also revealed that single nucleotide polymorphism of TREM2, such as R47H, increased the risk of Alzheimer's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
